Title : Nutrition for the future and the human microbiome - Dietary approaches to modulate gut microbial balance and support metabolic health
Abstract:
The human gut microbiome, comprising trillions of microorganisms, functions as a virtual endocrine organ that profoundly influences metabolic health through complex bidirectional communication with host physiological systems. Recent evidence demonstrates that dietary strategies targeting the gut microbiota represent promising therapeutic interventions for preventing and managing metabolic syndrome and related cardiometabolic disorders. Dietary fibre and fermented foods emerge as key modulators of gut microbial composition and function. Resistant carbohydrates undergo microbial fermentation in the colon, producing Short-Chain Fatty Acids (SCFAs), primarily acetate, propionate, and butyrate in a 60:20:20 ratio, of which 90-95% are absorbed and systemically distributed. These microbial metabolites regulate multiple metabolic pathways: Butyrate serves as the primary energy source for colonocytes while strengthening gut barrier integrity through tight junction formation, propionate enhances hepatic gluconeogenesis and improves insulin sensitivity, and acetate modulates lipid metabolism and appetite regulation via G-protein coupled receptors FFAR2 and FFAR3. Recent longitudinal studies reveal that long-term consumption of naturally fermented foods, including fermented dairy and legume products, induces significant shifts in gut microbial ecological states, with seasonal variations between Prevotella- and Bifidobacterium/Ruminococcus-driven community structures. These dietary interventions demonstrate the capacity to modulate the Firmicutes/Bacteroidetes ratio, enhance the production of beneficial metabolites, including fatty acid derivatives, and influence colonisation resistance patterns. The microbiota-gut-brain axis further extends these metabolic benefits through vagal nerve-mediated signalling, with cardiac vagal activity positively correlating with gut microbial diversity and inversely with inflammatory markers such as CRP and IL-6. Emerging evidence supports the concept of "psychobiotics"—probiotics that influence mental health through neurotransmitter production (GABA, serotonin, dopamine) and modulation of the hypothalamic-pituitary-adrenal axis. Precision nutrition approaches incorporating the Dietary Index for Gut Microbiota (DI-GM) are associated with a reduced prevalence of metabolic syndrome components, including abdominal obesity, dysglycemia, and dyslipidemia. Multi-omics integration, combining metagenomics, metabolomics, and transcriptomics, enables mechanistic elucidation of diet-microbiota-host interactions, facilitating development of personalised dietary interventions. These findings underscore the therapeutic potential of microbiome-targeted nutritional strategies, encompassing prebiotics, probiotics, synbiotics, and whole-food dietary patterns such as the Mediterranean diet for optimising metabolic health and preventing chronic disease. Future research should prioritise well-powered, long-term randomised controlled trials to establish clinical efficacy and develop evidence-based, personalised dietary recommendations for diverse populations.
